Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.33%177.03B | 5.96%776.59B | 11.15%185.04B | 9.52%732.93B | 9.67%184.01B | 7.61%198.55B | 9.67%183.9B | 11.53%166.47B | 17.47%669.25B | 15.77%167.78B |
| Cost of revenue | -1.20%116.57B | 6.19%503.64B | 8.75%117.98B | 5.83%474.3B | 7.26%122.98B | 3.50%125.52B | 4.66%117.32B | 8.32%108.49B | 19.44%448.17B | 15.56%114.65B |
| Gross profit | -9.83%60.46B | 5.54%272.95B | 15.64%67.06B | 16.99%258.63B | 14.87%61.04B | 15.48%73.03B | 19.77%66.58B | 18.06%57.98B | 13.66%221.08B | 16.22%53.14B |
| Operating expense | -1.55%47.63B | 6.80%211.8B | 20.24%48.39B | 14.34%198.31B | 20.88%59.68B | 17.56%52.25B | 7.45%46.13B | 9.69%40.24B | 14.45%173.44B | 15.97%49.38B |
| Selling and administrative expenses | -1.49%47.46B | 6.09%209.27B | 19.78%48.18B | 13.48%197.25B | 18.79%58.96B | 16.93%51.89B | 8.07%46.18B | 8.47%40.22B | 14.72%173.82B | 17.55%49.63B |
| -General and administrative expense | -1.49%47.46B | 6.09%209.27B | 19.78%48.18B | 13.48%197.25B | 18.79%58.96B | 16.93%51.89B | 8.07%46.18B | 8.47%40.22B | 14.72%173.82B | 17.55%49.63B |
| Other operating expenses | -6.97%427M | 28.69%4.36B | 12.22%459M | 95.05%3.39B | 231.27%1.93B | 42.48%701M | -31.03%349M | 162.18%409M | -13.71%1.74B | -49.17%582M |
| Total other operating income | 0.79%254M | -21.59%1.83B | -35.38%252M | 10.04%2.33B | 43.38%1.2B | -19.53%342M | 29.74%397M | -29.09%390M | 6.74%2.12B | 6.07%839M |
| Operating profit | -31.29%12.83B | 1.37%61.15B | 5.23%18.67B | 26.63%60.32B | -64.02%1.35B | 10.56%20.78B | 61.52%20.45B | 42.79%17.74B | 10.90%47.64B | 19.55%3.76B |
| Net non-operating interest income (expenses) | -28.37%765M | -31.63%2.43B | -1.20%1.07B | 53.65%3.55B | 177.35%1.21B | -9.42%769M | 67.92%492M | 47.28%1.08B | -9.93%2.31B | -18.16%437M |
| Non-operating interest income | 9.33%1.51B | 1.26%4.19B | 14.01%1.38B | 27.09%4.14B | 74.05%1.01B | 12.90%1.16B | 22.93%756M | 17.20%1.21B | 6.02%3.26B | -9.20%582M |
| Non-operating interest expense | 137.14%747M | 201.37%1.76B | 138.64%315M | -38.07%584M | -237.24%-199M | 121.84%386M | -18.01%264M | -56.15%132M | 87.48%943M | 35.51%145M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -5.30%3.02B | 1.37%13.22B | 1.59%3.19B | 63.02%13.04B | 8.80%3.45B | -0.14%2.88B | 220.72%3.58B | 276.92%3.14B | 118.76%8B | 260.23%3.17B |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -27.55%16.61B | -0.15%76.8B | 4.39%22.92B | 32.73%76.92B | -18.38%6.01B | 8.44%24.43B | 74.27%24.52B | 56.96%21.96B | 17.83%57.95B | 61.56%7.37B |
| Income tax | -19.56%4.79B | -1.61%17.9B | -12.64%5.96B | 90.19%18.2B | 96.73%-115M | 58.48%6.1B | 55.32%5.39B | 18.20%6.82B | -12.44%9.57B | -426.46%-3.52B |
| Net income | -30.35%11.82B | 0.30%58.89B | 12.06%16.97B | 21.36%58.72B | -43.73%6.13B | -1.88%18.32B | 80.49%19.12B | 84.17%15.14B | 26.47%48.38B | 108.18%10.89B |
| Net income continuous operations | -30.35%11.82B | 0.30%58.89B | 12.06%16.97B | 21.36%58.72B | -43.73%6.13B | -1.88%18.32B | 80.49%19.12B | 84.17%15.14B | 26.47%48.38B | 108.18%10.89B |
| Noncontrolling interests | -45.29%598M | -14.80%3.87B | -1.53%1.09B | 25.61%4.55B | -4.00%1.01B | 13.23%1.28B | 53.97%1.14B | 60.64%1.11B | 27.38%3.62B | 86.35%1.05B |
| Net income attributable to the company | -29.32%11.22B | 1.57%55.02B | 13.13%15.87B | 21.02%54.17B | -47.96%5.12B | -2.86%17.04B | 82.49%17.98B | 86.33%14.03B | 26.40%44.76B | 110.87%9.84B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -29.32%11.22B | 1.57%55.02B | 13.13%15.87B | 21.02%54.17B | -47.96%5.12B | -2.86%17.04B | 82.49%17.98B | 86.33%14.03B | 26.40%44.76B | 110.87%9.84B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -26.86%38.37 | 3.51%184.41 | 13.68%52.46 | 21.25%178.16 | -47.96%16.84 | -2.86%56.04 | 82.70%59.1333 | 87.51%46.1467 | 28.34%146.94 | 112.48%32.36 |
| Diluted earnings per share | -26.89%38.11 | 3.49%183.22 | 13.66%52.13 | 21.23%177.04 | -48.01%16.72 | -2.88%55.69 | 82.69%58.7667 | 87.45%45.8633 | 28.28%146.04 | 112.37%32.16 |
| Dividend per share | 0 | 5.00%70 | 0 | 42.86%66.6667 | 60.00%40 | 0 | 23.08%26.6667 | 0 | 16.67%46.6667 | 25.00%25 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |